Tata Chemicals Limited · NSE:TATACHEM
Tata Chemicals — Q3 FY2020 Earnings Presentation
20 slides from Tata Chemicals's earnings presentation, Feb 3, 2020
Slide 1: Submission of Analysts/Investors Presentation to stock exchanges
TI' ^-\ TATA February 3, 2020 The General Manager National Stock Exchange of lndia Ltd. Corporate Relations Department Exchange Plaza BSE Limited Bandra-Kurla Complex Phiroze Jee.ieebhoy Towers Bandra (E) Dalal Street Mumbai 400 051 Mumbai - 400 001 Svmbol: TATACHEM Scrio Code: 500770 Dear Sir, Sub:
Slide 2: Analyst / Investors Communication on Financial results for period ended December 2019
Analyst / Investors Communication on Financial results for period ended December 2019 Date: 3rd February 2020 1
Slide 3: Safe Harbour Statement
Safe Harbour Statement “This Presentation, except for the historical information, may contain statements, including the words or phrases such as ‘expects, anticipates, intends, will, would, undertakes, aims, estimates, contemplates, seeks to, objective, goal, projects, should’ and similar expression
Slide 4: Business Overview
Business Overview 3rd largest Soda Ash producer globally │5,000+ employees across 4 continents │160 million households consume Tata Salt each month 3
Slide 5: Our Journey till date
Our Journey till date Specialty Chemicals Specialty Chemicals Specialty Chemicals Consumer Business Consumer Business Basic Chemistry Basic Chemistry Basic Chemistry Fertilizer 2020 & beyond…. 2016 2018 …To 2 focused science driven From 4 businesses…. To 3 businesses…. chemistry businesses “Received
Slide 6: Business Updates
Business Updates Basic Chemistry Products Planned Schedule (MT) • Mithapur expansion plan is scheduled as planned. Products Soda Ash Bicarb Salt Caustic Cement • Acquired balance 25% stake in TCSAP from The Andover Group for USD 195 million. Existing 0.8 MMT 0.1MMT 1.0 MMT 9KMT 0.5 MMT Specialty Pro
Slide 7: Q3 Dec 2019 Financial Updates
Q3 Dec 2019 Financial Updates 6
Slide 8: Key Highlights
Key Highlights Consumer Products Business considered as Discontinued Operations Acquired balance 25% stake in TCSAP from The Andover Group for USD 195 million Revenue from Operations (Continuing Operation) Standalone for the quarter ended was at ₹ 756 Cr (vs PY ₹ 757 Cr) Consolidated for the period
Slide 9: Financial Updates: For the Quarter December 2019
Financial Updates: For the Quarter December 2019 Standalone (₹ Cr) 28% 26% 757 756 22% 211 195 165 17% 128 Q3 Dec 18 Q3 Dec 19 Q3 Dec 18 Q3 Dec 19 Q3 Dec 18 Q3 Dec 19 Revenue constant EBITDA up by 18% PAT* up by 64% Consolidated (₹ Cr) 18% 16% 473 10% 11% 2,620 412 288 266 2,570 Q3 Dec 18 Q3 Dec 19
Slide 10: Financial Updates: For the Period ended December 2019
Financial Updates: For the Period ended December 2019 Standalone (₹ Cr) 2,260 26% 35% 22% 30% 2,175 574 506 759 679 YTD Dec 18 YTD Dec 19 YTD Dec 18 YTD Dec 19 YTD Dec 18 YTD Dec 19 Revenue down by 4% EBITDA up by 13% PAT* up by 12% Consolidated (₹ Cr) 13% 7,968 19% 12% 17% 1,038 7,775 1,545 937 1,3
Slide 11: Segment Revenues and Results
Segment Revenues and Results Consolidated Standalone Rs Cr Q3 Dec 18 Q3 Dec 19 Q3 Dec 18 Q3 Dec 19 Basic Chemistry Products 2,142 2,007 746 726 Specialty Products 429 604 12 21 Less: Inter Segment Revenue (3) (3) - - 2,568 2,608 758 747 Unallocated Revenue 2 13 (1) 9 Total Segment Revenue 2,570 2,62
Slide 12: Segment Revenues and Results (with Discontinued Operations)
Segment Revenues and Results (with Discontinued Operations) Consolidated Standalone Rs Cr YTD Dec18 YTD Dec19 Q3 Dec18 Q3 Dec19 Continuing Segment Revenue 2,570 2,620 757 756 Operations Segment Results 292 367 177 204 Discontinued Segment Revenue 471 531 471 531 Operation Segment Results 57 82 57 82
Slide 13: Borrowings Position as on December 2019
Borrowings Position as on December 2019 Standalone (₹ Cr) 708 692 2,428 16 - (2,412) Gross Debt Mar19 Net Change Revaluation Gross Debt Dec19 Cash & Cash Equivalents Net Cash Consolidated (₹ Cr) 184 761 3,362 6,143 7,088 3,726 Gross Debt Mar'19 Net Change Revaluation Gross Debt Dec'19 Cash & Cash Eq
Slide 14: Segment: Basic Chemistry Products
Segment: Basic Chemistry Products Segment Revenues & Results (₹ Cr) • TCL India: Revenue at ₹726 Cr (down by 3%, vs PY ₹746 Cr), margins on the Soda ash continues to improve over PY, leading to Segment results at ₹213 Cr (up by 16%, PY ₹183 Cr). 2,142 • TCNA: Revenue at ₹872 Cr (down by 2%, vs PY ₹8
Slide 15: Segment: Specialty Products
Segment: Specialty Products Segment Revenues & Results (₹ Cr) • Nutritional Solutions and Other Specialty products: Revenues at ₹ 21 Cr vs PY ₹ 12 Cr, mainly on account of higher sales volumes. Margins where muted on account of higher marketing fixed cost. • Commercial production of non rubber & rub
Slide 16: Segment: Consumer Products Business (Discontinued operations)
Segment: Consumer Products Business (Discontinued operations) Segment Revenues & Results (₹ Cr) • Salt Business: Tata Salt continues to maintain its leadership position in the branded salt segment with market share more than 25% in the overall edible salt market and ~65% market share in branded Salt
Slide 17: Financial updates: Operating Entities
Financial updates: Operating Entities Statement of Profit and Loss (Continuing Operations) for the quarter ended Dec 2019 Units TCL India US UK Africa Rallis Consolidated* ₹ Cr PY CY PY CY PY CY PY CY PY CY PY CY Revenue 757 756 889 872 371 348 144 79 417 534 2,570 2,620 EBITDA 165 195 171 183 14 46
Slide 18: Volumes: Major Products
Volumes : Major Products Soda Ash (in Kts) Sodium Bicarbonate (in Kts) Salt Portfolio* (in Kts) TCL India TCE TCML TCNA TCL India TCE For the Quarter 566 587 27 27 28 29 569 569 293 301 80 78 63 263 264 40 85 94 28 31 83 70 24 27 172 158 203 208 Dec-18 Dec-19 Dec-18 Dec-19 Dec-18 Dec-19 Dec-18 Dec-1
Slide 19: Additional Information
Additional Information Revenues (₹ Cr) & PAT (%) Earnings Price Per Share (in ₹) 14% 9% 15% 9% 9% 2,767 2,570 2,561 2,580 2,620 13.4 11.6 7.1 6.8 6.2 Q3 FY19 Q4 FY19 Q1 FY20 Q2 FY20 Q3 FY20 Q3 FY19 Q4 FY19 Q1 FY20 Q2 FY20 Q3 FY20 Shareholding Pattern Exchange rate (Average) USD GBP Non 91.72 91.74 8
Slide 20: Contact details
aA - POR PAP pT AR POPPI PE AZAASA Ey AFA ALAA AZ ian ] ALAL SA Accelerating LIER WALKS PPLAZOA An focussed growth agnrm an ts AA aam Fo aAA o al ZaryZ For any question/queries please contact ax sy & John Mulhall & [email protected] © +91 226665 8282 & Sameer Kulkarni & sakulkarni@tatachemi